Age-related drug companies, funds seek new life as boomers near 80

It’s been 10 years since former Genentech CEO Art Levinson teamed with Google to launch Calico. Now new aging-focused companies and investors are boldly claiming they not only want to slow the aging process but stop it in its tracks.
Click here to view original post